You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 147 No. 3, March 1987 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL INVESTIGATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (34)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

A Reappraisal of the United Kingdom Epidemic of Fatal Asthma

Can General Mortality Data Implicate a Therapeutic Agent?

John M. Esdaile, MD, MPH; Alvan R. Feinstein, MD; Ralph I. Horwitz, MD

Arch Intern Med. 1987;147(3):543-549.


Abstract



• The 1960s epidemic of asthma deaths that affected young persons in England and Wales, as well as in other countries, was attributed to the effect of newly available pressurized aerosols containing sympathomimetic bronchodilators. The subsequent decision to ban the nonprescription sale of these agents in the United Kingdom represented a unique use of national and international mortality data. The application of such data for decisions about therapeutic agents has implications for the current rise of asthma deaths in New Zealand, for the recent United States regulatory action regarding the nonprescription sale of aerosolized bronchodilators, and for the appraisal of adverse reactions to other pharmaceutical substances. This article is concerned with the quality of the scientific evidence used to implicate bronchodilators in the 1960s epidemic, and also with the strengths and weaknesses of the ecologic studies on which the implication depended. After concluding that the causal link between asthma deaths and bronchodilators was not supported by satisfactory scientific evidence, we present new data and an alternative diagnostic-exchange hypothesis that may, in part, help explain the original association.

(Arch Intern Med 1987;147:543-549)



Author Affiliations



From the Departments of Medicine and Epidemiology, Yale University School of Medicine, New Haven, Conn (Drs Feinstein and Horwitz), and the Department of Medicine, McGill University, Montreal (Dr Esdaile).


Footnotes



Accepted for publication Sept 5,1986.

Reprint requests to Clinical Epidemiology Unit, Montreal General Hospital, 1650 Cedar Ave, Montreal, Quebec, Canada, H3G 1A4 (Dr Esdaile).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Case-Mix Adjustment Using Administrative Databases: A Paradigm to Guide Future Research
Wray et al.
Med Care Res Rev 1997;54:326-356.
ABSTRACT  

ICD, POR, and DRG: Unsolved Scientific Problems in the Nosology of Clinical Medicine
Feinstein
Arch Intern Med 1988;148:2269-2274.
ABSTRACT  

Reappraisal of the United Kingdom Epidemic of Fatal Asthma
Speizer and Doll
Arch Intern Med 1987;147:1853-1853.
ABSTRACT  

Reappraisal of the United Kingdom Epidemic of Fatal Asthma-Reply
Esdaile et al.
Arch Intern Med 1987;147:1853-1856.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.